We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Elana Bernstein MD, MSc

Elana J. Bernstein MD, MSc

Assistant Professor of Medicine; Director, Columbia University/NewYork-Presbyterian Scleroderma Program, Division of Rheumatology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York

Elana J. Bernstein, MD, MSc, is Assistant Professor of Medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons and Director of the Columbia University Scleroderma Program. Dr. Bernstein graduated summa cum laude from Amherst College, and was inducted into the Alpha Omega Alpha medical honor society while a medical student at the Mount Sinai School of Medicine. She completed her medicine residency at the Massachusetts General Hospital and her rheumatology fellowship at Hospital for Special Surgery. Dr. Bernstein’s research focuses on lung disease in systemic sclerosis, post-lung transplant outcomes of adults with systemic autoimmune rheumatic diseases, and the relationship between autoimmunity and interstitial lung disease. Dr. Bernstein has received grants from the National Institutes of Health, Rheumatology Research Foundation, and Arthritis Foundation to study lung disease in systemic sclerosis.


Dr. Bernstein reports the following:
  • Consultant: Boehringer Ingelheim
  • Grant/research support: Boehringer Ingelheim, Pfizer, Kadmon